Immediate Impact
11 standout
Citing Papers
Intratumoral Fusobacterium nucleatum Recruits Tumor-Associated Neutrophils to Promote Gastric Cancer Progression and Immune Evasion
2025 Standout
HER2-targeted therapies in cancer: a systematic review
2024 Standout
Works of Gengsheng Yu being referenced
S-1 plus oxaliplatin versus S-1 plus cisplatin as first-line treatment for advanced diffuse-type or mixed-type gastric/gastroesophageal junction adenocarcinoma: A randomized, phase 3 trial.
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Gengsheng Yu | 34 | 12 | 2 | 16 | 16 | 9 | 66 | |
| Daniela Fux | 56 | 30 | 22 | 39 | 11 | 163 | ||
| Federica Diofano | 45 | 10 | 9 | 7 | 9 | 94 | ||
| Antoniades Hn | 63 | 4 | 15 | 11 | 13 | 181 | ||
| Peter A. McAnulty | 72 | 6 | 1 | 4 | 20 | 9 | 164 | |
| Bianca E Suur | 37 | 4 | 8 | 8 | 10 | 109 | ||
| Masatomo Mihara | 33 | 7 | 12 | 40 | 9 | 170 | ||
| Krunal Shah | 21 | 5 | 20 | 30 | 12 | 94 | ||
| Alexandre A. Doueik | 34 | 3 | 30 | 10 | 10 | 100 | ||
| Inm Day | 38 | 9 | 6 | 7 | 5 | 69 | ||
| Elda Meta | 76 | 5 | 16 | 14 | 8 | 172 |
All Works
Login with ORCID to disown or claim papers
Loading papers...